These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5560913)

  • 1. Variations in synalbumin insulin antagonism during tolbutamide tolerance test.
    Bajaj JS; Vallance-Owen J
    Diabetologia; 1971 Jun; 7(3):133-5. PubMed ID: 5560913
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on the incidence of the synalbumin insulin antagonist.
    Bajaj JS; McMaster D; Vallance-Owen J
    Diabetologia; 1971 Jun; 7(3):136-8. PubMed ID: 5560914
    [No Abstract]   [Full Text] [Related]  

  • 3. Variations in synalbumin insulin antagonism during glucose-tolerance tests.
    Jervell J; Vallance-Owen J
    Lancet; 1967 Jun; 1(7502):1253-4. PubMed ID: 4165040
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
    Serrano-Rios M; Ramos F; Rodriguez-Miñon JL; Vivanco F
    Diabetologia; 1970 Aug; 6(4):392-8. PubMed ID: 5456764
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate but not long-term administration of nicardipine inhibits tolbutamide-induced insulin secretion from rat pancreatic beta cells.
    Liu CQ; Li XJ; Zhang W; Zhang HJ; Lin MZ; Yang SY
    Pancreas; 2010 May; 39(4):452-7. PubMed ID: 19959966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
    Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin secretion in Addison's disease: effect of hydrocortisone treatment.
    Serrano-Rios M; Hawkins FG; Escobar F; Mato JM; Larrodera L; De Oya M; Rodriguez-Miñon JL
    Horm Metab Res; 1974 Jan; 6(1):17-21. PubMed ID: 4819287
    [No Abstract]   [Full Text] [Related]  

  • 9. The response of infants of diabetic women to tolbutamide and leucine at birth, and to glucose and tolbutamide at 2 years of age.
    Velasco MS; Paulsen EP
    Pediatrics; 1969 Apr; 43(4):546-57. PubMed ID: 5777070
    [No Abstract]   [Full Text] [Related]  

  • 10. Derivation of a quantitative measure of insulin sensitivity from the intravenous tolbutamide test using the minimal model of glucose dynamics.
    Shennan NM; Godsland IF; Wynn V
    Diabetologia; 1987 May; 30(5):314-22. PubMed ID: 3301482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a delay in the plasma insulin response of patients with chemical diabetes mellitus?
    Reaven GM; Shen SW; Silvers A; Farquhar JW
    Diabetes; 1971 Jun; 20(6):416-23. PubMed ID: 5556900
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma insulin disturbances in primary hyperparathyroidism.
    Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
    J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin release during post-tolbutamide glucose test. Its effect in children with decreased insulin reserve.
    Cresto JC; Dujovne IL; Sires JM; Aparicio NJ; De Majo SF
    Medicina (B Aires); 1977; 37(2):133-8. PubMed ID: 331023
    [No Abstract]   [Full Text] [Related]  

  • 15. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

  • 18. Depressed tolbutamide-induced insulin response in subjects treated with propranolol.
    Massara F; Strumia E; Camanni F; Molinatti GM
    Diabetologia; 1971 Aug; 7(4):287-9. PubMed ID: 5093710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T; Lüders L; Bottermann P
    MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tolbutamide and insulin on insulin inhibitory activity associated with plasma albumin.
    Devrim S; Kilo C; Voyles N; Recant L
    Diabetes; 1968 Dec; 17(12):746-51. PubMed ID: 5726254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.